Current management of anemia in adult hemodialysis patients with end-stage renal disease

American Journal of Health-System Pharmacy

Volumn 59, Issue 5, 2002, Pages 429-435

  Frankenfield, Diane L ^a   Johnson, Curtis A ^a  

^a Center for Medicare and Medicaid Services   (United States)

Author keywords

Anemia; Dialysis; Disease management; Dosage; Drug use; Epoetin alfa; Hematopoietic agents; Injections; Iron; Iron preparations; Kidney failure; Race; Sex

Indexed keywords

ANTIANEMIC AGENT; FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIALYSIS; DISEASE MANAGEMENT; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEGRO; OUTCOMES RESEARCH; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL;

EID: 0036500930     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.5.429     Document Type: Article

References (18)

1. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
2. K/DOQI clinical practice guidelines for hemodialysis adequacy, 2000
3. Health care quality improvement program: A new approach
4. From the HCFA: ESRD core indicators project
5. Quality improvement activity directed at the national level: Examples from the Health Care Financing Administration
6. 2000 Annual report: ESRD clinical performance measures project
7. Morbidity and mortality of renal dialysis: An NIH consensus conference statement
8. Hematocrit level and associated mortality in hemodialysis
9. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team
10. Pharmacist participation on physician rounds and adverse drug events drug events in the intensive care unit
11. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes and health care costs
12. The impact of clinical pharmacy management on cardiovascular risk reduction in patients with established heart disease in a group model health maintenance organization
13. Prescribing problems and pharmacist interventions in community practice
14. Economic evaluations of clinical pharmacy services - 1988-1995
15. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting